Extra weight can stress the knees, leading to pain and a higher risk of knee replacement surgery. Adults who took a GLP-1 ...

Bottlenecks are likely at small airports, particularly in Spain, Portugal and Italy - be cautious travelling at peak times, ...

GLP-1 medications are the hottest way to lose weight, but are all versions of the drug being marketed to you safe? A San ...

Weight loss medications, including popular drugs like Ozempic and Wegovy, could significantly reduce the need for knee ...

Blockchain analytics firm Chainalysis has recently indicated that a shadow economy centered on peptides has expanded into a ...

Ousting Sir Keir Starmer as Prime Minister will reverse the ban on new oil and gas drilling in the North Sea, pro-drilling Labour MPs believe. A change in No 10 will break the power which the Energy ...

Roxanna Gapstur says monetizing innovations developed through the system's new tech partnership is "not out of the question." ...

Potentially best-in-mechanism immunogenicity profile, with only 3.7% of participants developing antidrug antibodies Complete blockade of TL1A ...

DexCom posts steady profits and global reach, while Insulet surges ahead with rapid revenue growth and a focused product line. Which strategy stands out?

Eli Lilly knows that its GLP-1 windfall comes with an end date, so it is acting now to prepare.

A Penn Medicine study found that women taking GLP‑1 drugs such as Wegovy had a slightly lower rate of breast cancer diagnoses ...

After capturing the North American market with Wegovy (semaglutide) and Zepbound (tirzepatide), Novo Nordisk A/S and Eli Lilly and Co. are advancing blockbuster glucagon-like peptide-1 (GLP-1) ...